CTEV Short Volume

Claritev Corporation (CTEV) operates in the Healthcare sector, specifically the Medical - Healthcare Information Services industry, with a market capitalization near $470.2M, listed on NYSE, employing roughly 2,700 people, carrying a beta of 0.77 to the broader market. Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. Led by Travis S. Dalton, public since 2020-04-03.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-05-15
Short Volume
84.3K
Total Volume
296.0K
Short %
28.48%
30-Day Avg Short %
66.71%

Showing 30 days of FINRA short volume data for Claritev Corporation.

Learn how short volume is reported and how to read the data →

Frequently asked CTEV short volume questions

What is the daily CTEV short volume?
As of May 15, 2026, Claritev Corporation (CTEV) short volume is 84.3K shares against 296.0K total reported volume, or 28.48% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is CTEV short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does CTEV short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.